Literature DB >> 18614350

Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells.

Joan S Lewis-Wambi1, Heather E Cunliffe, Helen R Kim, Amanda L Willis, V Craig Jordan.   

Abstract

Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is an intercellular adhesion molecule that is overexpressed in a wide variety of human cancers, including colon, breast and lung and is associated with tumourigenesis, tumour cell adhesion, invasion and metastasis. In this study, we showed that CEACAM6 was overexpressed in a panel of oestrogen receptor (ERalpha)-positive human breast cancer cell lines (MCF-7:5C and MCF-7:2A) that have acquired resistance to oestrogen deprivation, and this overexpression was associated with a more aggressive invasive phenotype in vitro. Expression array analysis revealed that MCF-7:5C and MCF-7:2A cells overexpressed CEACAM6 mRNA by 27-fold and 12-fold, respectively, and were 6-15-times more invasive compared to non-invasive wild-type MCF-7 cells which expressed low levels of CEACAM6. Suppression of CEACAM6 expression using small interfering RNA (siRNA) completely reversed migration and invasion of MCF-7:5C and MCF-7:2A cells and it significantly reduced phosphorylated Akt and c-Src expression in these cells. In conclusion, our findings establish CEACAM6 as a unique mediator of migration and invasion of drug resistant oestrogen-deprived breast cancer cells and suggest that this protein could be an important biomarker of metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614350      PMCID: PMC2778047          DOI: 10.1016/j.ejca.2008.05.016

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  40 in total

Review 1.  Cellular survival: a play in three Akts.

Authors:  S R Datta; A Brunet; M E Greenberg
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Epithelial-mesenchymal transitions in development and pathologies.

Authors:  Jean Paul Thiery
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

Review 4.  Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase.

Authors:  R J Jones; V G Brunton; M C Frame
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

5.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

6.  Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.

Authors:  S Schölzel; W Zimmermann; G Schwarzkopf; F Grunert; B Rogaczewski; J Thompson
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

8.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

Authors:  M Baum; A U Budzar; J Cuzick; J Forbes; J H Houghton; J G M Klijn; T Sahmoud
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

9.  Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway.

Authors:  Madhavi Sekharam; Haiyan Zhao; Mei Sun; Quan Fang; Qingbo Zhang; Zengqiang Yuan; Han C Dan; David Boulware; Jin Q Cheng; Domenico Coppola
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

10.  Akt2: a role in breast cancer metastasis.

Authors:  Noan-Minh Chau; Margaret Ashcroft
Journal:  Breast Cancer Res       Date:  2003-11-04       Impact factor: 6.466

View more
  28 in total

1.  Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells.

Authors:  Erina Iwabuchi; Yasuhiro Miki; Yoshiaki Onodera; Yukiko Shibahara; Kiyoshi Takagi; Takashi Suzuki; Takanori Ishida; Hironobu Sasano
Journal:  Clin Exp Metastasis       Date:  2019-06-20       Impact factor: 5.150

2.  Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.

Authors:  Eric A Ariazi; Heather E Cunliffe; Joan S Lewis-Wambi; Michael J Slifker; Amanda L Willis; Pilar Ramos; Coya Tapia; Helen R Kim; Smitha Yerrum; Catherine G N Sharma; Emmanuelle Nicolas; Yoganand Balagurunathan; Eric A Ross; V Craig Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

3.  CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits.

Authors:  Chitra Pattabiraman; Shiyuan Hong; Vignesh K Gunasekharan; Annapurna Pranatharthi; Jeevisha Bajaj; Sweta Srivastava; H Krishnamurthy; Aswathy Ammothumkandy; Venkat G Giri; Laimonis A Laimins; Sudhir Krishna
Journal:  Cancer Res       Date:  2014-09-29       Impact factor: 12.701

4.  The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.

Authors:  Joan S Lewis-Wambi; Helen Kim; Ramona Curpan; Ronald Grigg; Mohammed A Sarker; V Craig Jordan
Journal:  Mol Pharmacol       Date:  2011-07-07       Impact factor: 4.436

5.  Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis.

Authors:  Taylor E Escher; Asona J Lui; Eric S Geanes; Katherine R Walter; Ossama Tawfik; Christy R Hagan; Joan Lewis-Wambi
Journal:  Mol Cancer Res       Date:  2019-01-17       Impact factor: 5.852

6.  Molecular targeting of CEACAM6 using antibody probes of different sizes.

Authors:  Gang Niu; Yanal M Murad; Haokao Gao; Shuo Hu; Ning Guo; Orit Jacobson; Thanh-Dung Nguyen; Jianbing Zhang; Xiaoyuan Chen
Journal:  J Control Release       Date:  2012-05-05       Impact factor: 9.776

7.  Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.

Authors:  Sarina Cameron; Lilia Merida de Long; Mehlika Hazar-Rethinam; Eleni Topkas; Liliana Endo-Munoz; Andrew Cumming; Orla Gannon; Alexander Guminski; Nicholas Saunders
Journal:  Mol Cancer       Date:  2012-09-28       Impact factor: 27.401

8.  Discovery of pathway biomarkers from coupled proteomics and systems biology methods.

Authors:  Fan Zhang; Jake Y Chen
Journal:  BMC Genomics       Date:  2010-11-02       Impact factor: 3.969

9.  Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma.

Authors:  M Kobayashi; Y Miki; M Ebina; K Abe; K Mori; S Narumi; T Suzuki; I Sato; M Maemondo; C Endo; A Inoue; H Kumamoto; T Kondo; H Yamada-Okabe; T Nukiwa; H Sasano
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

10.  Effective combination gene therapy using CEACAM6-shRNA and the fusion suicide gene yCDglyTK for pancreatic carcinoma in vitro.

Authors:  Hongyu Long; Qingfu Li; Yuan Wang; Qian Li; Ting Liu; Jie Peng
Journal:  Exp Ther Med       Date:  2012-10-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.